Long-term outcomes of two ablation techniques for treatment of radio-recurrent prostate cancer.

Shiva Madhwan Nair Max PetersPiet KurverArnon LaviJoost J C VerhoeffJochem R N van der Voort van ZypMarieke J van SonJoseph L Chin

Published in: Prostate cancer and prostatic diseases (2020)

Although sHIFU had higher BCR and CRPC rates, there were no differences in PCSM when compared with sCT. The long-term oncological data on two ablation techniques highlighted that only 50% of patients started ADT after 10-year follow-up.

Keyphrases

prostate cancer
end stage renal disease
radical prostatectomy
ejection fraction
newly diagnosed
acute lymphoblastic leukemia
peritoneal dialysis
big data
rectal cancer
artificial intelligence
data analysis
replacement therapy